ArticleNeurotrauma reports2025
Associations of Plasma Lipids with Traumatic Brain Injury Outcomes: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study.
Article in Neurotrauma reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Hypocholesterolemia has been observed in acute trauma, but less is known about lipid levels in acute traumatic brain injury (TBI). Our objectives were to (1) compare day 1 post-injury lipid levels from individuals with acute TBI to orthopedic trauma and healthy controls and (2) investigate associations of day 1 post-TBI lipid levels with clinical outcomes over the first-year post-injury. A subset of 266 participants with TBI, 68 orthopedic trauma controls, and 58 healthy controls from the Transforming Research and Clinical Knowledge in TBI Study were included in analyses. Plasma total cholesterol and triglycerides were measured using the enzymatic colorimetric method, and high-density lipoprotein (HDL) was measured via direct homogeneous/enzymatic colorimetric methods. Low-density lipoprotein (LDL) values were calculated using the Friedewald formula. The primary TBI outcome was the Glasgow Outcome Scale-Extended (dichotomized as favorable [score = 5-8] versus unfavorable [score = 1-4] outcome and complete [score = 8] versus incomplete [score = 1-7] recovery; administered at 2 weeks, 3 months, 6 months, and 1-year post-injury). Age- and sex-adjusted total cholesterol and LDL cholesterol were lower among participants with TBI compared with orthopedic trauma and healthy controls (total cholesterol: 116.7 mg/dL [95% confidence interval or CI = 112.1-121.3] versus 137.8 mg/dL [95% CI = 129.1-146.5] and 130.2 mg/dL [95% CI = 120.6-139.9]; LDL cholesterol: 59.3 mg/dL [95% CI = 55.8-62.9] versus 77.7 mg/dL [95% CI = 71.1-84.3] and 72.4 mg/dL [95% CI = 65.1-79.7]). Adjusted levels of HDL cholesterol and triglycerides were similar by group. Among participants with TBI, higher day 1 post-injury total cholesterol, LDL, and triglyceride levels were associated with greater adjusted odds of favorable versus unfavorable outcome after injury. In conclusion, our study found that day 1 post-injury levels of total and LDL cholesterol were lower among individuals with TBI compared with both orthopedic trauma and healthy controls. Furthermore, our results suggest that individuals who did not have acutely low total cholesterol and LDL cholesterol, and, to a lesser extent, triglycerides, had better functional outcomes over the first-year post-TBI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.